Neointimal hyperplasia persists at six months after sirolimus-eluting stent implantation in diabetic porcine

Table 3 Angiographic and IVUS Follow-up Results

	Diabetic group (n = 15)	Control group (n = 15)
In-stent MLD(mm)	2.45 ± 0.32*	2.82 ± 0.21
In-segment MLD(mm)	2.43 ± 0.29*	2.79 ± 0.27
In-stent DS(%)	40.4 ± 24.0*	20.2 ± 17.7
In-segment DS(%)	43.1 ± 23.9*	21.3 ± 15.7
In-stent LL(mm)	0.33 ± 0.19*	0.10 ± 0.09
In-segment LL(mm)	0.31 ± 0.18*	0.10 ± 0.15
In-stent restenosis > 50% (number of stent)	6	2
Neointimal volume(mm³)	21.9 ± 18.7**	3.87 ± 2.89
%IH	26.7 ± 19.2**	7.3 ± 6.1

IVUS = intravascular ultrasound, MLD = minimal lumen diameter, DS = diameter stenosis, LL = late loss, %IH = percentage of intimal hyperplasia. *p < 0.05, **p < 0.001 vs. control group.

ISSN: 1475-2840